Severe Asthma
Severe asthma is a serious form of asthma that causes significant breathing difficulties and requires more intensive treatment. It can lead to frequent asthma attacks and may not respond well to standard medications.
Severe Asthma: Predicting Response to Benralizumab
We are studying whether early blood tests can predict how well severe asthma patients respond to Benralizumab treatment. This may help identify those who are likely to experience fewer asthma attacks.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have severe asthma that requires high doses of inhaled steroids or other medications to control?
- Are you currently pregnant, breastfeeding, or do you have the potential to become pregnant and are not using effective birth control?
- Have you had at least 3 asthma attacks in the past year?
- Have you ever received treatment with Benralizumab before?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-Pertuis
Respiratory medicine
Aix-en-Provence, France
Centre Hospitalier Universitaire D'Angers
Respiratory medicine
Angers, France
Centre Hospitalier Regional Et Universitaire De Brest
Respiratory medicine
Brest, France
Sponsor: Centre Hospitalier Universitaire De Nantes
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.